See why investors love the new 12-month forecast for Briacell Therapeutics Corp(BCTX)

white capsules on yellow background

Market Data

Briacell Therapeutics Corp(BCTX) is a stock of interest due to the large impact the company has on the market. Here at Wall Street Facts we only cover the best stocks so make sure you check out our other articles. Today we will be diving deep into all of the essential information you need to know about BCTX. We will be studying the movement so you can make the best decision as an investor. The stock has moved upwards today by 2.36%. The high for today is 3.08 and today’s low is 2.95. This information is critical in deciding whether this investment is risky or not. We can see the stock is trending upwards, which means the volume of people buying this stock is greater than people selling it.

Company Description

BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

Stock Forecast

As an investor, you can get an idea of where the stock is trending by the forecast. In this case, the high forecast for Briacell Therapeutics Corp is $12.00 and the low forecast is $9.00. Overall, Briacell Therapeutics Corp is in great shape going forward. They have a strong market cap of $24.37M and a very bright future ahead of them.

Leave a Reply

%d bloggers like this: